Answers are grounded in this paper and cite their sources.
Siraitia grosvenorii is a traditional Chinese medicine with four main species in China. Its special botanical properties and cultivation requirement make it most suitable to be grown in the Guangxi Province of China. Siraitia grosvenorii's functional components include cucurbitane-type triterpenoid glycosides, flavonoids, polysaccharides, and others. Among these, the widely utilized component is mogroside, which is a sweet agent with the characteristics of high sweetness and low calories. Although traditional methods have been used to extract these components, advanced technologies are needed to improve extraction efficiency. In recent years, the commercialization of Siraitia grosvenorii extract or utilization of mogroside have attracted industrial attention, evidenced by the increasing number of new products and patent registration. This review summarizes the functional components of Siraitia grosvenorii with their extraction methods, as well as the most recent Siraitia grosvenorii product development and patent registration status. The future potential application of Siraitia grosvenorii was also proposed.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: